CD169+ macrophages are increased in idiopathic inflammatory myopathies [55], indicating a prominent role in type I Interferon-related immune processes [56], and recent studies emphasized their highly specific functional programs and important roles as border-associated cells at blood vessel/parenchymal interfaces [57, 58]. Here, SIGLEC1 is linked to idiopathic inflammatory myopathy.